Lao People's Democratic Republic vs Liberia: Net oda to medical research
Lao People's Democratic Republic
51.32 million
in 2023
Liberia
58.91 million
in 2023
Lao People's Democratic Republic rank
52nd
Liberia rank
49th
Net oda to medical research over time
- Lao People's Democratic Republic
- Liberia
How they compare
Liberia currently reports 58.91 million against 51.32 million in Lao People's Democratic Republic, a difference of 7.59 million.
That makes Liberia's figure about 1.1 times Lao People's Democratic Republic's.
The two have swapped places 2 times across 14 shared years of data; in 2010 it was Liberia ahead.
Lao People's Democratic Republic ranks 52nd and Liberia ranks 49th of 139 countries.
Across the 2 decades both report, Lao People's Democratic Republic averaged higher in 1 and Liberia in 1.
Head to head by decade
| Decade | Lao People's Democratic Republic | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 35.43 million | 93.70 million | 58.27 million | Liberia |
| 2020s | 66.95 million | 55.77 million | 11.18 million | Lao People's Democratic Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher net oda to medical research, Lao People's Democratic Republic or Liberia?
- Liberia, at 58.91 million against 51.32 million in Lao People's Democratic Republic as of 2023.
- What is the difference in net oda to medical research between Lao People's Democratic Republic and Liberia?
- 7.59 million, with Liberia ahead.
- How many years of comparable data are there for Lao People's Democratic Republic and Liberia?
- 14 years are reported by both, from 2010 to 2023.
- How do Lao People's Democratic Republic and Liberia rank globally for net oda to medical research?
- Lao People's Democratic Republic ranks 52nd and Liberia ranks 49th of 139 countries.
- Where does this data come from?
- Our World in Data, published as Net oda to medical research. Statizoid refreshes it automatically from the source and publishes the full history for both places.